News
Promotions
10. January 2024
BGPartner congratulates Victoria Marty on her promotion to Senior Associate I and Thomas Gysin on his promotion to Senior Associate II.
Both have been an integral part of the BGPartner team for several years and have contributed significantly to the overall success of our firm. We are proud to grow together with our employees.
More information about our entire team can be found here.
New team members
03. January 2024
BGPartner is pleased to welcome Natascha Figoutz (Jurist at the Zurich office) and Ramon Lochmatter (Trainee at the Berne office) as of January 3, 2024. Further information on our entire team can be found here.
LAWorld EMEA Meeting Versailles
01. December 2023
The answer to the question "what makes a professional network strong" is multifaceted. However, one thing is clear: a network is only as strong as the relationships among its members. And this is cultivated at LAWorld in the form of regular get-togethers.
We are proud to be part of this positive development and will continue to write the success stories of LAWorld. Thanks again to our partner CAP LEGAL AARPI, you were a perfect host. We not only benefited professionally from the event in Versailles, but also had a lot of fun.
We are hiring
22. November 2023
At the Berne location, we are looking for a Lawyer (80 - 100%) and for a Office Manager (80 - 100%). More about this.
BGPartner advises Memo Therapeutics Ltd on its CHF 25 million Series C financing round
02. November 2023
Memo Therapeutics Ltd is a late-stage biotech company developing best-in-class therapeutic antibodies to transform the lives of patients with virus infections and cancer. MTx will use the proceeds to complete U.S. Phase II clinical development of its best- and first-in-class antibody, AntiBKV, intended to neutralize BK polyomavirus (BKV) infection in kidney transplant recipients.
The Series C financing round was led by Pureos Bioventures. Existing investors Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital, GF Group, Fresenius Medical Care Ventures and Red Alpine joined in the round.
The BGPartner team assisting Memo Therapeutics Ltd in all legal and negotiation matters was led by Oliver Gnehm (Partner) and further consisted of Victoria Marty (Associate) and Barbara Meise (Associate).
BGPartner is a top Swiss law firm in the area of Private Equity and Venture Capital and has won various awards.
Click here for the complete media release.
More information about our legal and negotiation expertise can be found here.